Home › Funds › TANG CAPITAL MANAGEMENT LLC › NVCT

TANG CAPITAL MANAGEMENT LLC position in NVCT

NUVECTIS PHARMA INC · Health Care

TANG CAPITAL MANAGEMENT LLC reported holding 1,577,968 shares of NVCT (NUVECTIS PHARMA INC) in its Q3 2026 13F filing — a position valued at US$33.3M, representing 1.53% of its reported portfolio and ranking #18 among its reported holdings. TANG CAPITAL MANAGEMENT LLC has disclosed NVCT holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

Latest position (Q3 2026)1.58M sh
Reported value held$33.33M
Portfolio Weight1.53%
First reportedQ2 2026
Last changeAdd
Updated2026-11-17

Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR

How TANG CAPITAL MANAGEMENT LLC's NVCT position evolved

TANG CAPITAL MANAGEMENT LLC first disclosed a stake in NVCT in Q2 2026 at 1,550,000 shares (US$28.5M). The position peaked in Q3 2026 at 1,577,968 shares, worth US$33.3M. Across 2 filings, TANG CAPITAL MANAGEMENT LLC increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 1,577,968 shares valued at US$33.3M — an increase of 27,968 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q2 2026 1.55M $28.50M New
Q3 2026 1.58M $33.33M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About NVCT and 13F data

NVCT (NUVECTIS PHARMA INC) is a Health Care company. 62 other funds we track also report a position in NVCT — the largest reported positions include Soleus Capital Management, L.P. (US$36.1M), BRAIDWELL LP (US$33.2M), IRIDIAN ASSET MANAGEMENT LLC/CT (US$16.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding NVCT

All NVCT fund holders →

FAQ

How long has TANG CAPITAL MANAGEMENT LLC held NVCT?

TANG CAPITAL MANAGEMENT LLC has disclosed NVCT holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

What is TANG CAPITAL MANAGEMENT LLC's current position in NVCT?

As of Q3 2026, TANG CAPITAL MANAGEMENT LLC holds 1.58M shares of NVCT (NUVECTIS PHARMA INC), valued at $33.33M, representing 1.53% of its reported portfolio and ranking #18.

Has TANG CAPITAL MANAGEMENT LLC been buying or selling NVCT?

In the latest 13F filing (Q3 2026), TANG CAPITAL MANAGEMENT LLC increased its position in NVCT. The position peaked in Q3 2026 at 1.58M shares.

Which other funds hold NVCT?

Other major institutional holders of NVCT include Soleus Capital Management, L.P., BRAIDWELL LP, IRIDIAN ASSET MANAGEMENT LLC/CT, among 62 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.